Rapid immunoassay test for qualitative detection of SARS-CoV-2 IgG and IgM antibodies in human serum or plasma. Designed for quick serological screening and diagnosis of COVID-19 infection status. Results available within minutes with sensitivity up to 4x higher than manual testing methods.
Manufactured by
TERSACO AG
Immensee, Switzerland
Swiss based company developing and marketing products crafted to the needs of small and middle size laboratories worldwide with a focus on biochemistry and POCT.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Lumigenex (Suzhou) Co., Ltd
China · 6 relevant products
Soluções em Diagnóstico e Biotecnologia
Brazil · 2 relevant products
Innovation Biotech (Beijing) Co., Ltd
China · 3 relevant products
69 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 119 closest product alternatives
Lumigenex (Suzhou) Co., Ltd · China
A rapid test kit for detecting SARS-CoV-2 IgG and IgM antibodies in patient samples using colloidal gold immunochromatographic technology. The kit provides qualitative results for COVID-19 serology testing.
Soluções em Diagnóstico e Biotecnologia · Brazil
Rapid immunochromatographic test kit for qualitative detection of SARS-CoV-2 IgM and IgG antibodies in serum, plasma, or whole blood samples. Provides results within 10-15 minutes, enabling quick identification of acute and past coronavirus infections in clinical and point-of-care settings.
Innovation Biotech (Beijing) Co., Ltd · China
Rapid immunochromatographic test device for qualitative detection of SARS-CoV-2 IgM and IgG antibodies in human serum, plasma, or whole blood. Provides results within 15-20 minutes, enabling quick identification of COVID-19 infection status in clinical and point-of-care settings.
116 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products